Compounds > benzyl selenocyanate

Page last updated: 2024-08-26

benzyl selenocyanate and 1,4-phenylenebis(methylene)selenocyanate

benzyl selenocyanate has been researched along with 1,4-phenylenebis(methylene)selenocyanate in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (50.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dutour, R; Poirier, D	1
Conaway, CC; el-Bayoumy, K; Kurtzke, C; Marcus, LA; Meschter, CL; Upadhyaya, P	1
El-Bayoumy, K; Pittman, B; Rao, CV; Reddy, BS; Rivenson, A; Upadhyaya, P	1
El-Bayoumy, K; Guengerich, FP; Shimada, T; Sutter, TR; Upadhyaya, P; Yamazaki, H	1
Amin, S; Bewley, MC; Chen, KM; Das, A; De Cotiis, DA; Desai, D; El-Bayoumy, K; Fiala, ES; Flanagan, JM; Spratt, TE; Stanley, BA	1
Guengerich, FP; Komori, M; Murayama, N; Shimada, T; Takenaka, S; Tanaka, K; Yamazaki, H	1

Reviews

1 review(s) available for benzyl selenocyanate and 1,4-phenylenebis(methylene)selenocyanate

Article	Year
Inhibitors of cytochrome P450 (CYP) 1B1. European journal of medicinal chemistry, 2017, Jul-28, Volume: 135 Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship	2017

Other Studies

5 other study(ies) available for benzyl selenocyanate and 1,4-phenylenebis(methylene)selenocyanate

Article	Year
Subchronic toxicity of benzyl selenocyanate and 1,4-phenylenebis(methylene)selenocyanate in F344 rats. Fundamental and applied toxicology : official journal of the Society of Toxicology, 1992, Volume: 19, Issue:4 Topics: Animals; Antineoplastic Agents; Body Weight; Cyanates; Dose-Response Relationship, Drug; Female; Kidney; Liver; Male; Organ Size; Organoselenium Compounds; Rats; Rats, Inbred F344	1992
Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets. Journal of the National Cancer Institute, 1997, Apr-02, Volume: 89, Issue:7 Topics: Adenocarcinoma; Analysis of Variance; Animals; Anticarcinogenic Agents; Azoxymethane; Colonic Neoplasms; Cyanates; Dietary Fats; Dose-Response Relationship, Drug; Incidence; Logistic Models; Male; Neoplasm Invasiveness; Organoselenium Compounds; Rats; Rats, Inbred F344	1997
Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds. Cancer research, 1997, Nov-01, Volume: 57, Issue:21 Topics: Animals; Anthracenes; Anticarcinogenic Agents; Benzyl Compounds; Carcinogens; Cyanates; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 Enzyme System; Humans; Male; Microsomes; Microsomes, Liver; Organoselenium Compounds; Oxazines; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Saccharomyces cerevisiae; Salmonella typhimurium; Sodium Selenite; Xenobiotics	1997
Inhibition of nuclear factor-kappaB DNA binding by organoselenocyanates through covalent modification of the p50 subunit. Cancer research, 2007, Nov-01, Volume: 67, Issue:21 Topics: Amino Acid Sequence; Anticarcinogenic Agents; Cyanates; Dithiothreitol; DNA; Humans; Mass Spectrometry; Models, Molecular; Molecular Sequence Data; NF-kappa B; NF-kappa B p50 Subunit; Organoselenium Compounds	2007
Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds. Chemical research in toxicology, 2011, Aug-15, Volume: 24, Issue:8 Topics: Animals; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Binding Sites; Biocatalysis; Catalytic Domain; Computer Simulation; Cyanates; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP1B1; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Neoplasms; Organoselenium Compounds; Protein Binding; Rats	2011